Corneal Transplantation clinical trials at UCLA
1 in progress, 0 open to eligible people
Showing trials for
ExCrossV Multi Site Trial for Vascularized High Risk Keratoplasty
Sorry, not yet accepting patients
The main objective of this study is to determine the safety of Ex Vivo Cross Linking (CXL) of donor corneal tissue in participants who have undergone high-risk penetrating keratoplasty.
Los Angeles, California and other locations
Our lead scientists for Corneal Transplantation research studies include Anthony Aldave, MD.
Last updated: